The randomized clinical trial will include 2,000 participants at high risk for an undiagnosed irregular heartbeat. It will compare patients wearing an Apple Watch and outfitted with the Mayo Clinic ECG Study App to people in a control group receiving usual care.
The study is expected to start in September and conclude in 2026. Mayo Clinic researchers previously found the Apple Watch could be used for identifying patients with a weak heart pump.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
